Search results
Investigator-Initiated Trial of Jaguar Health’s Crofelemer Yields Positive Results for Functional...
Digital Journal· 2 days agoThese include statements regarding the expectation that the study investigators will submit an abstract on the study to a peer-reviewed journal in 2024. In some cases, you ...
... on Pilot Study Data from Phase 2 Combination Clinical Trial Evaluating Motixafortide in...
WKRN Nashville· 6 days ago...BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that an abstract including new data from the single-arm pilot phase of the investigator-initiated, randomized CheMo4METPANC Phase 2 combination clinical...
Zealand Pharma announces topline results from the mechanistic investigator-led DREAM trial with low...
Benzinga· 6 days agoNo lifestyle interventions, such as diet or exercise...
‘The third man in the room’: Is Allen Weisselberg the ‘missing piece’ in Trump’s trial?
The Independent US via AOL· 2 days agoJust before he was sent to Rikers, he signed a $2m severance deal with...Organization “verbally or...
Seabrook man charged with possessing and distributing child sex abuse images
Portsmouth Herald via Yahoo News· 13 hours agoAccording to Mone, Seabrook police detective Thomas Butcher is the investigator who worked with ICAC...
UCB Announces Publication in The Lancet of Phase 3 BIMZELX® (bimekizumab-bkzx) Trials in...
The Arab Tribune· 7 days agoUCB, a global biopharmaceutical company, today announced that The Lancet has published results from the Phase 3 BE HEARD I and BE HEARD II trials evaluating the efficacy and safety of BIMZELX ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 6 days agoHOOKIPA to present an oral abstract at the American Society for Clinical Oncology (ASCO) 2024 Annual Meeting on June 4Updated data of HB-200 plus pembrolizumab demonstrate a favorable safety profile and promising clinical activity In a subset
CancerLinQ Enables Oncology's Largest Learning Network and Precision Oncology Solutions with...
Clearfield Progress· 1 day agoCancerLinQ®, the precision oncology care and research platform, originally founded by the American Society of Clinical Oncology (ASCO®) and now an initiative of ConcertAI, deploys advanced clinical ...
Federal agent spends lengthy day on witness stand at Karen Read trial, testifies to flirtatious...
The Sun Chronicle· 5 days agoDuring testimony Friday at the murder trial of Karen Read, a federal agent denied he provided ...
Penn Medicine at the 2024 ASCO Annual Meeting | Newswise
Newswise· 7 days agoResearchers from Penn Medicine’s Abramson Cancer Center (ACC) and the Perelman School of Medicine at the University of Pennsylvania will present data on the latest advances in cancer research ...